StockpollyBeta
Get App
Popularity #419
GH · NASDAQ · Medical - Diagnostics & Research

Guardant Health (GH)

Blood and tissue cancer tests spanning screening, monitoring, and treatment selection.

$176.73
vs last close−0.44 (−0.25%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue143155168177191202203232265281302335
Cost of revenue58636572747875819499105116
Gross profit8593103105117124129151172182197219
199290203205234250240257271303318348
Research & development949084838794898790989197
105117119122147157151170181204227252
Selling & marketing6979808298105104120127143169190
General & administrative363839404952475053615862
Other expenses0830000000000
Operating income−114−198−100−101−117−126−111−106−99−121−121−129
2810−15−210161676−9109
Interest income121415141312987101110
Interest expense111111111111
Other non-operating income−29−11141−10−16−17−8−78−11−11
Income before tax−86−188−115−102−108−110−95−100−93−130−112−120
Income tax expense0−10001000−200
Net income from continuing operations−86−187−115−103−108−111−95−100−93−128−112−120
Net income−86−187−115−103−108−111−95−100−93−128−112−120
EPS, basic−$0.73−$1.58−$0.94−$0.84−$0.88−$0.90−$0.77−$0.80−$0.74−$1.00−$0.85−$0.90
EPS, diluted−$0.73−$1.58−$0.94−$0.84−$0.88−$0.90−$0.77−$0.80−$0.74−$1.00−$0.85−$0.90
Weighted average shares, basic118119122122123124124124125129131132
Weighted average shares, diluted118119122122123124124124125129131132
EBITDA−74−176−103−91−96−99−84−89−82−119−101−109
Depreciation & amortization1111111111101010910910
EBIT−85−187−114−102−107−110−94−99−92−129−110−119